BACKGROUND: Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, recurrent, debilitating disease, which inflicts a significant burden on patients and is associated with comorbid disorders, such as significantly reduced quality of life, depression, stigmatization, inactivity, working disability, impairment of sexual health and several cardiovascular risk factors. AIMS/ METHODS: To implement an expert consensus on the diagnostic criteria, severity and classification assessment, and an assessment of anti-inflammatory treatment effectiveness based on current evidence. RESULTS: This article provides criteria for diagnosis, severity assessment, classification and evaluation of HS patients. CONCLUSION: The provided criteria can be used as tools for the promotion of uniformity in HS evaluation and facilitation of early and timely identification and referral in the primary care setting and thorough and efficient evaluation in daily clinical practice.
BACKGROUND:Hidradenitis suppurativa/acne inversa (HS) is a chronic, inflammatory, recurrent, debilitating disease, which inflicts a significant burden on patients and is associated with comorbid disorders, such as significantly reduced quality of life, depression, stigmatization, inactivity, working disability, impairment of sexual health and several cardiovascular risk factors. AIMS/ METHODS: To implement an expert consensus on the diagnostic criteria, severity and classification assessment, and an assessment of anti-inflammatory treatment effectiveness based on current evidence. RESULTS: This article provides criteria for diagnosis, severity assessment, classification and evaluation of HS patients. CONCLUSION: The provided criteria can be used as tools for the promotion of uniformity in HS evaluation and facilitation of early and timely identification and referral in the primary care setting and thorough and efficient evaluation in daily clinical practice.
Authors: R Sabat; A Tsaousi; J Rossbacher; H Kurzen; T Fadai; U Schwichtenberg; S Schneider-Burrus; G Kokolakis; K Wolk Journal: Hautarzt Date: 2017-12 Impact factor: 0.751
Authors: Hans Christian Ring; Jonathan Thorsen; Ditte M Saunte; Berit Lilje; Lene Bay; Peter Theut Riis; Niels Larsen; Lee O'Brien Andersen; Henrik V Nielsen; Iben M Miller; Thomas Bjarnsholt; Kurt Fuursted; Gregor Borut Jemec Journal: JAMA Dermatol Date: 2017-09-01 Impact factor: 10.282
Authors: Dylan Haynes; Phoebe Hammer; Stephen J Malachowski; Benjamin Kaffenberger; Jonathan S Yi; Nora Vera; Cody Calhoun; Michi M Shinohara; Lucia Seminario-Vidal; John C Trinidad; Jesse J Keller; Alex G Ortega-Loayza Journal: Int Wound J Date: 2019-09-02 Impact factor: 3.315
Authors: Eran Shavit; Afsaneh Alavi; Falk G Bechara; Richard G Bennett; Marc Bourcier; Ricardo Cibotti; Steven Daveluy; John W Frew; Amit Garg; Iltefat Hamzavi; Lauren K Hoffman; Jenny Hsaio; Joslyn Sciacca Kirby; Hadar Lev-Tov; Erin Martinez; Robert Micheletti; Haley B Naik; Aude Nassif; Cynthia Nicholson; Angie Parks-Miller; Zarine Patel; Vincent Piguet; Mayur Ramesh; Barry Resnik; Christopher Sayed; Gregory Schultz; Aamir Siddiqui; Jerry Tan; Ximena Wortsman; Michelle A Lowes Journal: Exp Dermatol Date: 2019-01 Impact factor: 3.960
Authors: Erin K Collier; Ram K Parvataneni; Michelle A Lowes; Haley B Naik; Martin Okun; Vivian Y Shi; Jennifer L Hsiao Journal: Am J Obstet Gynecol Date: 2020-09-24 Impact factor: 8.661